Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differences in the phenotype and in vivo anti-tumor activity of wti specific and ebv-specific T-cells generated in vitro for adoptive immunotherapy
    Meeting Abstract

    Doubrovina, E.; Dupont, J.; Kanaeva, E.; Doubrovin, M.; O'reilly, R.
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy
    Meeting Abstract

    Dotan, Z. A.; Sathyamoorthy, K.; Bianco, F. J.; Stephenson, A. J.; Eastham, J. A.; Fearn, P.; Schoder, H.; Scher, H. I.; Scardino, P. T.; Kattan, M. W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Systems pathology for building predictive models: The androgen receptor as a prototype biomarker in prostate cancer progression and targeted therapeutic response assessment
    Meeting Abstract

    Donovan, M. J.; Scher, H.; Scardino, P.; Kotsianti, A.; Cordon-Cardo, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Repetitive non-invasive imaging of genetically modified immune and tumor cells in vivo
    Meeting Abstract

    Dobrenkov, K.; Dabrowska, M.; Shenker, L.; Vider, E.; Sadelain, M.; Ponomarev, V.
    Cytotherapy (2006)

    Fulltext@MSK | Save
  • PIK3CA mutation is frequent in class A estrogen receptor-negative breast cancer and contributes to the distinct molecular profile
    Meeting Abstract

    Doane, A. S.; Moynahan, M. E.; Zhang, L.; Hudis, C.; Gerald, W. L.
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Distinct PIK3CA mutation profiles in estrogen receptor (ER) negative breast cancer (BC) subsets
    Meeting Abstract

    Doane, A. S.; Danso, M.; Lal, P.; Donaton, M.; Wheler, J.; Moynahan, M.; Zhang, L.; Hudis, C.; Gerald, W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I safety and immunogenicity study of NY-ESO-1b peptide and Montanide ISA-51 vaccination of patients with ovarian cancer (OC) in high risk first remission
    Meeting Abstract

    Diefenbach, C. S. M.; Sabbatini, P.; Aghajanian, C.; Spriggs, D.; Lee, H.; Pezzulli, S.; Jungbluth, A. A.; Old, L. J.; Gnjatic, S.; Dupont, J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Vaccinia virus down-regulates NF-kappaB pathway through a novel mechanism
    Meeting Abstract

    Deng, L.; Dai, P.; Shuman, S.
    Journal of Investigative Dermatology (2006)

    Fulltext@MSK | Save
  • Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Norton, L.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save